Please login to the form below

Not currently logged in
Email:
Password:

cholesterol

This page shows the latest cholesterol news and features for those working in and with pharma, biotech and healthcare.

ViiV’s two-drug HIV combo backed by CHMP

ViiV’s two-drug HIV combo backed by CHMP

Amgen also received a positive opinion on its bid to add cardiovascular outcomes data to the label of its cholesterol drug Repatha (evolocumab).

Latest news

More from news
Approximately 26 fully matching, plus 480 partially matching documents found.

Latest Intelligence

  • Tools for the digital world Tools for the digital world

    One study showed that patients with uncontrolled hypertension and diabetes achieved significantly greater reduction in blood pressure (BP) and LDL cholesterol, and were more likely to reach their BP goal, than

  • Challenging times Challenging times

    continents. We surveyed 21, 300 research participants with a range of chronic diseases including but not limited to high blood pressure, high cholesterol, diabetes, asthma, heart conditions and cancer.

  • Pharma deals in September 2015 Pharma deals in September 2015

    Amgen's busy month (part 2). Following FDA approval for its novel PCSK9 treatment for “ bad cholesterol”, Amgen is moving onto tackle dyslipidemia, an asymptomatic disease in which serum lipid levels ... Dezima's TA-8995 (phase 2b-complete), is an

  • Community pharmacy and OTC healthcare Community pharmacy and OTC healthcare

    Pharmacists' wellness and prevention role means intervening when people are still well and many provide services such as weight management, smoking cessation and cholesterol and blood pressure monitoring.

  • Pharma deals during November 2014 Pharma deals during November 2014

    In July, BioMarin sold its PRV to Regeneron for $68m to expedite filing of its cholesterol drug, the PCSK9 inhibitor alirocumab, being developed in partnership with Sanofi.

More from intelligence
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
EY Life Sciences

Our global reach Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics